Brown, Lisle/Cummings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Brown, Lisle/Cummings's ABBV Position: Q3 2026 in Review
Brown, Lisle/Cummings reduced its AbbVie (ABBV) stake by 3.6% in Q3 2026, selling an estimated $267K and leaving 27,953 shares worth $7.31M. The position accounts for 1.61% of the portfolio, ranked #12.
Brown, Lisle/Cummings first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Brown, Lisle/Cummings held 27,953 shares of AbbVie worth $7.31M as of Q3 2026.
- Brown, Lisle/Cummings sold 1,043 AbbVie shares in Q3 2026, an estimated $267K.
- AbbVie made up 1.61% of Brown, Lisle/Cummings's portfolio in Q3 2026, its #12 holding.
- Brown, Lisle/Cummings first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q3 2026, filed 16 Oct 2026.